Effect of Lactoferrin on Clinical Outcomes of Hospitalized Patients with COVID-19: The LAC Randomized Clinical Trial
Erica Matino, Elena Tavella, Manuela Rizzi, Gian Carlo Avanzi, Danila Azzolina, Antonio Battaglia, Paolo Becco, Mattia Bellan, Giovanni Bertinieri, Massimo Bertoletti, Giuseppe Francesco Casciaro, Luigi Mario Castello, Umberto Colageo, Donato Colangelo, Davide Comolli, Martina Costanzo, Alessandro Croce, Davide D’onghia, Francesco Della Corte, Luigi De Mitri, Valentina Dodaro, Filippo Givone, Alessia Gravina, Luca Grillenzoni, Graziano Gusmaroli, Raffaella Landi, Anna Lingua, Roberto Manzoni, Vito Marinoni, Bianca Masturzo, Rosalba Minisini, Marina Morello, Anna Nelva, Elena Ortone, Rita Paolella, Giuseppe Patti, Anita Pedrinelli, Mario Pirisi, Lidia Ravizzi, Eleonora Rizzi, Daniele Sola, Mariolina Sola, Nadir Tonello, Stelvio Tonello, Gigliola Topazzo, Aldo Tua, Piera Valenti, Rosanna Vaschetto, Veronica Vassia, Erika Zecca, Nicoletta Zublena, Paolo Manzoni, Pier Paolo Sainaghi
Nutrients, doi:10.3390/nu15051285
As lactoferrin is a nutritional supplement with proven antiviral and immunomodulatory abilities, it may be used to improve the clinical course of COVID-19. The clinical efficacy and safety of bovine lactoferrin were evaluated in the LAC randomized double-blind placebo-controlled trial. A total of 218 hospitalized adult patients with moderate-to-severe COVID-19 were randomized to receive 800 mg/die oral bovine lactoferrin (n = 113) or placebo (n = 105), both given in combination with standard COVID-19 therapy. No differences in lactoferrin vs. placebo were observed in the primary outcomes: the proportion of death or intensive care unit admission (risk ratio of 1.06 (95% CI 0.63-1.79)) or proportion of discharge or National Early Warning Score 2 (NEWS2) ≤ 2 within 14 days from enrollment (RR of 0.85 (95% CI 0.70-1.04)). Lactoferrin showed an excellent safety and Nutrients 2023, 15, 1285. https://doi.org/10.3390/nu15051285 https://www.mdpi.com/journal/nutrients tolerability profile. Even though bovine lactoferrin is safe and tolerable, our results do not support its use in hospitalized patients with moderate-to-severe COVID-19.
Conflicts of Interest: The authors declare no conflict of interest.
References
Al-Alaiyan, Abdulaziz, Alkohlani, Almairi, Al Hazzani et al., Effects of Probiotics and Lactoferrin on Necrotizing Enterocolitis in Preterm Infants, Cureus,
doi:10.7759/cureus.18256Algahtani, Elabbasy, Sanak, Adeboye, Yusuf et al., The prospect of lactoferrin use ad adjunctive agent in management of SARS-CoV-2 patients: A randomized pilot study, Medicina,
doi:10.3390/medicina57080842Alt, median (IQR), U/L
Andersen, Jenssen, Sandvik, Gutteberg, Anti-HSV activity of lactoferrin and lactoferricin is dependent on the presence of heparan sulphate at the cell surface, J. Med. Virol,
doi:10.1002/jmv.20171Ansems, Grundeis, Dahms, Mikolajewska, Thieme et al., Remdesivir for the Treatment of COIVD-19, Cochrane Database of Systematic Reviews,
doi:10.1002/14651858.CD014962/fullArribas, Bhagani, Lobo, Khaertynova, Mateu et al., Randomized Trial of Molnupiravir or Placebo in Patients Hospitalized with COVID-19, NEJM
Ast, median (IQR, U/L
Barrington, Assaad, Janvier, The Lacuna Trial: A double-blind randomized controlled pilot trial of lactoferrin supplementation in the very preterm infant, J. Perinatol,
doi:10.1038/jp.2016.24Berlutti, Pantanella, Natalizi, Frioni, Paesano et al., Antiviral properties of lactoferrin-A natural immunity molecule, Molecules,
doi:10.3390/molecules16086992Cabaro, D'esposito, Di Matola, Sale, Cennamo et al., Cytokine signature and COVID-19 prediction models in the two waves of pandemics, Sci. Rep,
doi:10.1038/s41598-021-00190-0Cairns, Dulko, Griffiths, Golan, Cohen et al., Efficacy of niclosamide vs placebo in SARS-CoV-2 respiratory viral clearance, viral shedding, and duration of symptoms among patients with mild to moderate COVID-19. A phase 2 randomized clinical trial, JAMA Netw. Open,
doi:10.1001/jamanetworkopen.2021.44942Campione, Cosio, Rosa, Lanna, Di Girolamo et al., Lactoferrin as protective natural barrier of respiratory and intestinal mucosa against coronavirus infection and inflammation, Int. J. Mol. Sci
Campione, Lanna, Cosio, Rosa, Conte et al., Lactoferrin against SARS-COV-2: In Vitro and in silico evidences, Front. Pharmacol,
doi:10.3389/fphar.2021.666600Campione, Lanna, Cosio, Rosa, Conte et al., Lactoferrin as Antiviral Treatment in COVID-19 Management: Preliminary Evidence, Int. J. Environ. Res. Public Health,
doi:10.3390/ijerph182010985Champely, Ekstrom, Dalgaard, Gill, Weibelzahl et al., Pwr", R Package Version
Chen, Liu, Guo, Emerging coronaviruses: Genome structure, replication, and pathogenesis, J. Med. Virol,
doi:10.1002/jmv.25681Cohen, Statistical Power Analysis for the Behavioral Sciences
Core, A Language and Environment for Statistical Computing; R Foundation for Statistical Computing; R Core Team
Creatinine, None
Crp, None
Dhama, Khan, Tiwari, Sircar, Bhat et al., Coronavirus Disease 2019-COVID-19, Clin. Microbiol. Rev,
doi:10.1128/CMR.00028-20Ding, Zhang, Zhang, Huang, Yang et al., Prognostic Role and Diagnostic Power of Seven Indicators in COVID-19 Patients, Front. Med,
doi:10.3389/fmed.2021.733274Dyer, Covid-19: Unvaccinated face 11 times risk of death from delta variant, CDC data show, BMJ,
doi:10.1136/bmj.n2282Ferritin, median (IQR
Fischer, Debbabi, Blais, Dubarry, Rautureau et al., Uptake of ingested bovine lactoferrin and its accumulation in adult mouse tissues, Int. Immunopharmacol,
doi:10.1016/j.intimp.2007.05.019Gavriatopoulou, Ntanasis-Stathopoulos, Korompoki, Fotiou, Migkou et al., Emerging treatment strategies for COVID-19 infection, Clin. Exp. Med,
doi:10.1007/s10238-020-00671-yGottlieb, Vaca, Paredes, Mera, Webb et al., Early Remdesivir to Prevent Progression to Severe Covid-19 in Outpatients, N. Engl. J. Med,
doi:10.1056/NEJMoa2116846Griffiths, Jenkins, Vargova, Bowler, Juszczak et al., Enteral lactoferrin to prevent infection for very preterm infants: The ELFIN RCT, Health Technol. Assess,
doi:10.3310/hta22740Habib, Ibrahim, Zaim, Ibrahim, The role of iron in the pathogenesis of COVID-19 and possible treatment with lactoferrin and other iron chelators, Biomed. Pharmacother,
doi:10.1016/j.biopha.2021.111228Harris, Taylor, Thielke, Payne, Gonzalez et al., Research electronic data capture (REDCap)-A metadatadriven methodology and workflow process for providing translational research informatics support, J. Biomed. Inform,
doi:10.1016/j.jbi.2008.08.010He, Cai, Yu, Prophylactic lactoferrin for preventing late-onset sepsis and necrotizing enterocolitis in preterm infants. A PRISMA-complaint systematic review and meta-analysis, Medicine,
doi:10.1097/MD.0000000000011976Hemoglobin, median (IQR
Hoxa, Hodaj, Potential role of lactoferrin and heparin in COIVD-19: A review, Eur. Sci. J. ESJ
Hu, Meng, Zhang, Xiang, Wang, The in vitro antiviral activity of lactoferrin against common human coronaviruses and SARS-CoV-2 is mediated by targeting the heparan sulfate co-receptor, Emerg. Microbes Infect,
doi:10.1080/22221751.2021.1888660Jiang, Lopez, Kelleher, Lönnerdal, Apo-and holo-lactoferrin are both internalized by lactoferrin receptor via clathrin-mediated endocytosis but differentially affect ERK-signaling and cell proliferation in caco-2 cells, J. Cell. Physiol,
doi:10.1002/jcp.22650Kaur, Gatwala, Efficacy of bovine lactoferrin supplementation in preventing late-onset sepsis in low birth weight neo-nates: A randomized placebo-controlled clinical trial, J. Trop. Pediatr,
doi:10.1093/tropej/fmv044Kawakami, Lonnerdal, Isolation and function of a receptor for human lactoferrin in human fetal intestinal brush-border membranes, Am. J. Physiol,
doi:10.1152/ajpgi.1991.261.5.G841Kitagawa, Yoshizawa, Yokoyama, Takeuchi, Talukder et al., Persorption of bovine lactoferrin from the intestinal lumen into the systemic circulation via the portal vein and the mesenteric lymphatics in growing pigs, J. Vet.-Med. Sci,
doi:10.1292/jvms.65.567Kochi, Tagliari, Forleo, Fassini, Tondo, Cardiac and arrhythmic complications in patients with COVID-19, J. Cardiovasc. Electrophysiol,
doi:10.1111/jce.14479Lang, Yang, Deng, Liu, Yang et al., Inhibition of SARS Pseudovirus Cell Entry by Lactoferrin Binding to Heparan Sulfate Proteoglycans, PLoS ONE,
doi:10.1371/journal.pone.0023710Ldh, None, U/L
Legrand, Elass, Carpentier, Mazurier, Interactions of lactoferrin with cells involved in immune function, Biochem. Cell Biol,
doi:10.1139/o06-045Lopez, Kelleher, Lönnerdal, Lactoferrin receptor mediates apo-but not hol-lactoferrin internalization via clath-rinmediated endocytosis in trophoblasts, Biochem. J,
doi:10.1042/BJ20070393Manzoni, Meyer, Stolfi, Rinaldi, Cattani et al., Bovine lactoferrin supplementation for prevention of necrotizing enterocolitis in very-low-birth-weight neonates: A randomized clinical trial, Early Hum. Dev,
doi:10.1016/S0378-3782(14)70020-9Manzoni, Rinaldi, Cattani, Pugni, Romeo et al., Bovine lactoferrin supplementation for prevention of late-onset sepsis in very low-birth-weight neonates: A randomized trial, JAMA,
doi:10.1001/jama.2009.1403Miotto, Di Rienzo, Bò, Boffi, Ruocco et al., Molecular mechanisms behind anti SARS-CoV-2 action of lactoferrin, Front. Mol. Biosci,
doi:10.3389/fmolb.2021.607443Mirabelli, Wotring, Zhang, Mccarty, Fursmidt et al., Morphological cell profiling of SARS-CoV-2 infection identifies drug repurposing candidates for COVID-19, Proc. Natl. Acad. Sci,
doi:10.1073/pnas.2105815118Ochoa, Loli, Mendoza, Carcamo, Bellomo et al., Effect of bovine lactoferrin on prevention of late-onset sepsis in infants < 1500 g: A pooled analysis of individual patient data from two randomized controlled trials, Biochem. Cell Biol,
doi:10.1139/bcb-2020-0046Ochoa, Zegarra, Bellomo, Carcamo, Cam et al., Randomized controlled trial of bovine lactoferrin for prevention of sepsis and neuro-development impairment in infants weighing less than 2000 grams, J. Pediatr,
doi:10.1016/j.jpeds.2019.12.038Ochoa, Zegarra, Cam, Llanos, Pezo et al., Randomized Controlled Trial of Lactoferrin for Prevention of Sepsis in Peruvian Neonates Less than 2500 g, Pediatr. Infect. Dis. J,
doi:10.1097/INF.0000000000000593Osuchowski, Winkler, Skirecki, Cajander, Shankar-Hari et al., The COVID-19 puzzle: Deciphering pathophysiology and phenotypes of a new disease entity, Lancet Respir. Med,
doi:10.1016/S2213-2600(21)00218-6Presti, Manti, Parisi, Papale, Barbagallo et al., Lactoferrin: Cytokine modulation and application in clinical partice, J. Clin. Med,
doi:10.3390/jcm10235482Redwan, Uversky, El-Fakharany, Al-Mehdar, Potential lactoferrin activity against pathogenic viruses, Comptes Rendus Biol,
doi:10.1016/j.crvi.2014.08.003Ricordi, Pacifici, Lanzoni, Palamara, Garaci et al., Dietary and Protective Factors to Halt or Mitigate Progression of Autoimmunity, COVID-19 and Its Associated Metabolic Diseases, Int. J. Mol. Sci,
doi:10.3390/ijms22063134Rosa, Cutone, Conte, Campione, Bianchi et al., An overview on in vitro and in vivo antiviral activity of lactoferrin: Its efficacy against SARS-CoV-2 infection, BioMetals,
doi:10.1007/s10534-022-00427-zRosa, Cutone, Lepanto, Paesano, Valenti, Lactoferrin: A natural glycoprotein involved in iron and inflammatory homeostasis, Int. J. Mol. Sci,
doi:10.3390/ijms18091985Rosa, Tripepi, Naldi, Aimati, Santangeli et al., Ambulatory COVID-19 Patients Treated with Lactoferrin as a Supplementary Antiviral Agent: A Preliminary Study, J. Clin. Med,
doi:10.3390/jcm10184276Rosemberger, Lachin, Randomization and the Clinical Trial
Salaris, Scarpa, Elli, Bertolini, Guglielmetti et al., Protective effects of lactoferrin against SARS-CoV-2 infection in vitro, Nutrients,
doi:10.3390/nu13020328Serrano, Kochergina, Albors, Diaz, Oroval et al., Liposomal Lactoferrin as Potential Preventative and Cure for COVID-19, Int. J. Res. Health Sci,
doi:10.5530/ijrhs.8.1.3Shafqat, Shafqat, Al Salameh, Kashir, Alkattan et al., Mechanistic Insights into the Immune Pathophysiology of COVID-19
Suresh, An overview of randomization techniques: An unbiased assessment of outcome in clinical research, J. Hum. Reprod. Sci,
doi:10.4103/0974-1208.82352Tarnow-Mordi, Abdel-Latif, Martin, Pammi, Robledo et al., The effect of lactoferrin supplementation on death or major morbidity in very low birthweight infants (LIFT): A multicentre, double-blind, randomised controlled trial, Lancet Child Adolesc. Health,
doi:10.1016/S2352-4642(20)30093-6Troponin, median (IQR
Wen, Chen, Tang, Wang, Zhou et al., Efficacy and safety of three new oral antiviral treatment (molnupiravir, fluvoxamine and Paxlovid) for COVID-19: A meta-analysis, Ann. Med,
doi:10.1080/07853890.2022.2034936Wotring, Fursmidt, Ward, Sexton, Evaluating the in vitro efficacy of bovine lactoferrin products against SARS-CoV-2 variants of concern, J. Diary Sci,
doi:10.3168/jds.2021-21247Yang, Jiang, Chen, Wang, Duan et al., Concentration of lactoferrin in human milk and its variation during lactation in different Chinese populations, Nutrients,
doi:10.3390/nu10091235DOI record:
{
"DOI": "10.3390/nu15051285",
"ISSN": [
"2072-6643"
],
"URL": "http://dx.doi.org/10.3390/nu15051285",
"abstract": "<jats:p>As lactoferrin is a nutritional supplement with proven antiviral and immunomodulatory abilities, it may be used to improve the clinical course of COVID-19. The clinical efficacy and safety of bovine lactoferrin were evaluated in the LAC randomized double-blind placebo-controlled trial. A total of 218 hospitalized adult patients with moderate-to-severe COVID-19 were randomized to receive 800 mg/die oral bovine lactoferrin (n = 113) or placebo (n = 105), both given in combination with standard COVID-19 therapy. No differences in lactoferrin vs. placebo were observed in the primary outcomes: the proportion of death or intensive care unit admission (risk ratio of 1.06 (95% CI 0.63–1.79)) or proportion of discharge or National Early Warning Score 2 (NEWS2) ≤ 2 within 14 days from enrollment (RR of 0.85 (95% CI 0.70–1.04)). Lactoferrin showed an excellent safety and tolerability profile. Even though bovine lactoferrin is safe and tolerable, our results do not support its use in hospitalized patients with moderate-to-severe COVID-19.</jats:p>",
"alternative-id": [
"nu15051285"
],
"author": [
{
"affiliation": [
{
"name": "Department of Translational Medicine, Università del Piemonte Orientale (UPO), 28100 Novara, Italy"
},
{
"name": "Department of Internal Medicine and COVID-19 Unit, Azienda Ospedaliero-Universitaria (AOU) “Maggiore della Carità”, 28100 Novara, Italy"
},
{
"name": "Division of Emergency Medicine and COVID-19 Sub-Intensive Unit, Azienda Ospedaliero-Universitaria (AOU) “Maggiore della Carità”, 28100 Novara, Italy"
}
],
"family": "Matino",
"given": "Erica",
"sequence": "first"
},
{
"ORCID": "http://orcid.org/0000-0003-3396-0609",
"affiliation": [
{
"name": "Department of Maternal-Infant Medicine, Ospedale degli Infermi, 13875 Ponderano, Italy"
},
{
"name": "Internal Medicine, Department of Medical Sciences, Azienda Ospedaliero-Universitaria (AOU) Città della Salute e della Scienza, University of Turin School of Medicine, 10126 Turin, Italy"
}
],
"authenticated-orcid": false,
"family": "Tavella",
"given": "Elena",
"sequence": "additional"
},
{
"ORCID": "http://orcid.org/0000-0002-6174-7111",
"affiliation": [
{
"name": "Department of Health Sciences, Università del Piemonte Orientale (UPO), 28100 Novara, Italy"
}
],
"authenticated-orcid": false,
"family": "Rizzi",
"given": "Manuela",
"sequence": "additional"
},
{
"affiliation": [
{
"name": "Department of Translational Medicine, Università del Piemonte Orientale (UPO), 28100 Novara, Italy"
},
{
"name": "Division of Emergency Medicine and COVID-19 Sub-Intensive Unit, Azienda Ospedaliero-Universitaria (AOU) “Maggiore della Carità”, 28100 Novara, Italy"
}
],
"family": "Avanzi",
"given": "Gian Carlo",
"sequence": "additional"
},
{
"ORCID": "http://orcid.org/0000-0002-8185-5742",
"affiliation": [
{
"name": "Department of Translational Medicine, Università del Piemonte Orientale (UPO), 28100 Novara, Italy"
}
],
"authenticated-orcid": false,
"family": "Azzolina",
"given": "Danila",
"sequence": "additional"
},
{
"affiliation": [
{
"name": "Division of Dermatology, Ospedale degli Infermi, 13875 Ponderano, Italy"
}
],
"family": "Battaglia",
"given": "Antonio",
"sequence": "additional"
},
{
"affiliation": [
{
"name": "Division of Oncology, Ospedale degli Infermi, 13875 Ponderano, Italy"
}
],
"family": "Becco",
"given": "Paolo",
"sequence": "additional"
},
{
"ORCID": "http://orcid.org/0000-0003-1488-8736",
"affiliation": [
{
"name": "Department of Translational Medicine, Università del Piemonte Orientale (UPO), 28100 Novara, Italy"
},
{
"name": "Division of Emergency Medicine and COVID-19 Sub-Intensive Unit, Azienda Ospedaliero-Universitaria (AOU) “Maggiore della Carità”, 28100 Novara, Italy"
},
{
"name": "CAAD, Center for Autoimmune and Allergic Diseases, Università del Piemonte Orientale (UPO), 28100 Novara, Italy"
}
],
"authenticated-orcid": false,
"family": "Bellan",
"given": "Mattia",
"sequence": "additional"
},
{
"affiliation": [
{
"name": "Division of Internal Medicine, Ospedale degli Infermi, 13875 Ponderano, Italy"
}
],
"family": "Bertinieri",
"given": "Giovanni",
"sequence": "additional"
},
{
"affiliation": [
{
"name": "Division of Pneumology, Ospedale degli Infermi, 13875 Ponderano, Italy"
}
],
"family": "Bertoletti",
"given": "Massimo",
"sequence": "additional"
},
{
"affiliation": [
{
"name": "Department of Translational Medicine, Università del Piemonte Orientale (UPO), 28100 Novara, Italy"
},
{
"name": "Department of Internal Medicine and COVID-19 Unit, Azienda Ospedaliero-Universitaria (AOU) “Maggiore della Carità”, 28100 Novara, Italy"
},
{
"name": "Division of Emergency Medicine and COVID-19 Sub-Intensive Unit, Azienda Ospedaliero-Universitaria (AOU) “Maggiore della Carità”, 28100 Novara, Italy"
}
],
"family": "Casciaro",
"given": "Giuseppe Francesco",
"sequence": "additional"
},
{
"ORCID": "http://orcid.org/0000-0001-8248-1976",
"affiliation": [
{
"name": "Department of Translational Medicine, Università del Piemonte Orientale (UPO), 28100 Novara, Italy"
},
{
"name": "Division of Internal Medicine, Azienda Ospedaliera “SS. Antonio e Biagio e Cesare Arrigo”, 15121 Alessandria, Italy"
}
],
"authenticated-orcid": false,
"family": "Castello",
"given": "Luigi Mario",
"sequence": "additional"
},
{
"affiliation": [
{
"name": "Intensive Care Unit, Ospedale degli Infermi, 13875 Ponderano, Italy"
}
],
"family": "Colageo",
"given": "Umberto",
"sequence": "additional"
},
{
"ORCID": "http://orcid.org/0000-0003-2277-3226",
"affiliation": [
{
"name": "Department of Health Sciences, Università del Piemonte Orientale (UPO), 28100 Novara, Italy"
}
],
"authenticated-orcid": false,
"family": "Colangelo",
"given": "Donato",
"sequence": "additional"
},
{
"affiliation": [
{
"name": "Department of Translational Medicine, Università del Piemonte Orientale (UPO), 28100 Novara, Italy"
}
],
"family": "Comolli",
"given": "Davide",
"sequence": "additional"
},
{
"affiliation": [
{
"name": "Department of Translational Medicine, Università del Piemonte Orientale (UPO), 28100 Novara, Italy"
},
{
"name": "Department of Internal Medicine and COVID-19 Unit, Azienda Ospedaliero-Universitaria (AOU) “Maggiore della Carità”, 28100 Novara, Italy"
},
{
"name": "Division of Emergency Medicine and COVID-19 Sub-Intensive Unit, Azienda Ospedaliero-Universitaria (AOU) “Maggiore della Carità”, 28100 Novara, Italy"
}
],
"family": "Costanzo",
"given": "Martina",
"sequence": "additional"
},
{
"affiliation": [
{
"name": "Department of Translational Medicine, Università del Piemonte Orientale (UPO), 28100 Novara, Italy"
},
{
"name": "Department of Internal Medicine and COVID-19 Unit, Azienda Ospedaliero-Universitaria (AOU) “Maggiore della Carità”, 28100 Novara, Italy"
},
{
"name": "Division of Emergency Medicine and COVID-19 Sub-Intensive Unit, Azienda Ospedaliero-Universitaria (AOU) “Maggiore della Carità”, 28100 Novara, Italy"
}
],
"family": "Croce",
"given": "Alessandro",
"sequence": "additional"
},
{
"ORCID": "http://orcid.org/0000-0002-3196-940X",
"affiliation": [
{
"name": "Department of Translational Medicine, Università del Piemonte Orientale (UPO), 28100 Novara, Italy"
}
],
"authenticated-orcid": false,
"family": "D’Onghia",
"given": "Davide",
"sequence": "additional"
},
{
"ORCID": "http://orcid.org/0000-0003-1736-2318",
"affiliation": [
{
"name": "Department of Translational Medicine, Università del Piemonte Orientale (UPO), 28100 Novara, Italy"
},
{
"name": "Department of Anesthesia and Intensive Care Medicine, AOU “Maggiore della Carità”, 28100 Novara, Italy"
}
],
"authenticated-orcid": false,
"family": "Della Corte",
"given": "Francesco",
"sequence": "additional"
},
{
"affiliation": [
{
"name": "Division of Diabetology and Endocrinology, Ospedale degli Infermi, 13875 Ponderano, Italy"
}
],
"family": "De Mitri",
"given": "Luigi",
"sequence": "additional"
},
{
"affiliation": [
{
"name": "Internal Medicine, Department of Medical Sciences, Azienda Ospedaliero-Universitaria (AOU) Città della Salute e della Scienza, University of Turin School of Medicine, 10126 Turin, Italy"
}
],
"family": "Dodaro",
"given": "Valentina",
"sequence": "additional"
},
{
"affiliation": [
{
"name": "Division of Pneumology, Ospedale degli Infermi, 13875 Ponderano, Italy"
}
],
"family": "Givone",
"given": "Filippo",
"sequence": "additional"
},
{
"affiliation": [
{
"name": "Division of Emergency Medicine, Ospedale degli Infermi, 13875 Ponderano, Italy"
}
],
"family": "Gravina",
"given": "Alessia",
"sequence": "additional"
},
{
"affiliation": [
{
"name": "Division of Emergency Medicine, Ospedale degli Infermi, 13875 Ponderano, Italy"
}
],
"family": "Grillenzoni",
"given": "Luca",
"sequence": "additional"
},
{
"affiliation": [
{
"name": "Division of Neurology, Ospedale degli Infermi, 13875 Ponderano, Italy"
}
],
"family": "Gusmaroli",
"given": "Graziano",
"sequence": "additional"
},
{
"affiliation": [
{
"name": "Department of Translational Medicine, Università del Piemonte Orientale (UPO), 28100 Novara, Italy"
},
{
"name": "Department of Internal Medicine and COVID-19 Unit, Azienda Ospedaliero-Universitaria (AOU) “Maggiore della Carità”, 28100 Novara, Italy"
},
{
"name": "Division of Emergency Medicine and COVID-19 Sub-Intensive Unit, Azienda Ospedaliero-Universitaria (AOU) “Maggiore della Carità”, 28100 Novara, Italy"
}
],
"family": "Landi",
"given": "Raffaella",
"sequence": "additional"
},
{
"affiliation": [
{
"name": "Division of Infectious Disease, Ospedale degli Infermi, 13875 Ponderano, Italy"
}
],
"family": "Lingua",
"given": "Anna",
"sequence": "additional"
},
{
"affiliation": [
{
"name": "Division of Dermatology, Ospedale degli Infermi, 13875 Ponderano, Italy"
}
],
"family": "Manzoni",
"given": "Roberto",
"sequence": "additional"
},
{
"affiliation": [
{
"name": "Division of Geriatric Care, Ospedale degli Infermi, 13875 Ponderano, Italy"
}
],
"family": "Marinoni",
"given": "Vito",
"sequence": "additional"
},
{
"ORCID": "http://orcid.org/0000-0001-5243-0940",
"affiliation": [
{
"name": "Division of Obstetrics and Gynecology, Ospedale degli Infermi, 13875 Ponderano, Italy"
}
],
"authenticated-orcid": false,
"family": "Masturzo",
"given": "Bianca",
"sequence": "additional"
},
{
"ORCID": "http://orcid.org/0000-0002-7548-9731",
"affiliation": [
{
"name": "Department of Translational Medicine, Università del Piemonte Orientale (UPO), 28100 Novara, Italy"
}
],
"authenticated-orcid": false,
"family": "Minisini",
"given": "Rosalba",
"sequence": "additional"
},
{
"affiliation": [
{
"name": "Division of Emergency Medicine, Ospedale degli Infermi, 13875 Ponderano, Italy"
}
],
"family": "Morello",
"given": "Marina",
"sequence": "additional"
},
{
"affiliation": [
{
"name": "Division of Diabetology and Endocrinology, Ospedale degli Infermi, 13875 Ponderano, Italy"
}
],
"family": "Nelva",
"given": "Anna",
"sequence": "additional"
},
{
"affiliation": [
{
"name": "Division of Geriatric Care, Ospedale degli Infermi, 13875 Ponderano, Italy"
}
],
"family": "Ortone",
"given": "Elena",
"sequence": "additional"
},
{
"affiliation": [
{
"name": "Division of Emergency Medicine, Ospedale degli Infermi, 13875 Ponderano, Italy"
}
],
"family": "Paolella",
"given": "Rita",
"sequence": "additional"
},
{
"ORCID": "http://orcid.org/0000-0002-5404-3968",
"affiliation": [
{
"name": "Department of Translational Medicine, Università del Piemonte Orientale (UPO), 28100 Novara, Italy"
},
{
"name": "Medical Department, Division of Cardiology, AOU “Maggiore della Carità”, 28100 Novara, Italy"
}
],
"authenticated-orcid": false,
"family": "Patti",
"given": "Giuseppe",
"sequence": "additional"
},
{
"affiliation": [
{
"name": "Department of Translational Medicine, Università del Piemonte Orientale (UPO), 28100 Novara, Italy"
},
{
"name": "Department of Internal Medicine and COVID-19 Unit, Azienda Ospedaliero-Universitaria (AOU) “Maggiore della Carità”, 28100 Novara, Italy"
},
{
"name": "Division of Emergency Medicine and COVID-19 Sub-Intensive Unit, Azienda Ospedaliero-Universitaria (AOU) “Maggiore della Carità”, 28100 Novara, Italy"
}
],
"family": "Pedrinelli",
"given": "Anita",
"sequence": "additional"
},
{
"affiliation": [
{
"name": "Department of Translational Medicine, Università del Piemonte Orientale (UPO), 28100 Novara, Italy"
},
{
"name": "Department of Internal Medicine and COVID-19 Unit, Azienda Ospedaliero-Universitaria (AOU) “Maggiore della Carità”, 28100 Novara, Italy"
},
{
"name": "Division of Emergency Medicine and COVID-19 Sub-Intensive Unit, Azienda Ospedaliero-Universitaria (AOU) “Maggiore della Carità”, 28100 Novara, Italy"
},
{
"name": "CAAD, Center for Autoimmune and Allergic Diseases, Università del Piemonte Orientale (UPO), 28100 Novara, Italy"
}
],
"family": "Pirisi",
"given": "Mario",
"sequence": "additional"
},
{
"affiliation": [
{
"name": "Division of Pneumology, Ospedale degli Infermi, 13875 Ponderano, Italy"
}
],
"family": "Ravizzi",
"given": "Lidia",
"sequence": "additional"
},
{
"ORCID": "http://orcid.org/0000-0001-9615-2452",
"affiliation": [
{
"name": "Department of Translational Medicine, Università del Piemonte Orientale (UPO), 28100 Novara, Italy"
},
{
"name": "Department of Internal Medicine and COVID-19 Unit, Azienda Ospedaliero-Universitaria (AOU) “Maggiore della Carità”, 28100 Novara, Italy"
},
{
"name": "Division of Emergency Medicine and COVID-19 Sub-Intensive Unit, Azienda Ospedaliero-Universitaria (AOU) “Maggiore della Carità”, 28100 Novara, Italy"
}
],
"authenticated-orcid": false,
"family": "Rizzi",
"given": "Eleonora",
"sequence": "additional"
},
{
"ORCID": "http://orcid.org/0000-0001-7863-8192",
"affiliation": [
{
"name": "Department of Translational Medicine, Università del Piemonte Orientale (UPO), 28100 Novara, Italy"
},
{
"name": "Department of Internal Medicine and COVID-19 Unit, Azienda Ospedaliero-Universitaria (AOU) “Maggiore della Carità”, 28100 Novara, Italy"
}
],
"authenticated-orcid": false,
"family": "Sola",
"given": "Daniele",
"sequence": "additional"
},
{
"affiliation": [
{
"name": "Division of Emergency Medicine, Ospedale degli Infermi, 13875 Ponderano, Italy"
}
],
"family": "Sola",
"given": "Mariolina",
"sequence": "additional"
},
{
"affiliation": [
{
"name": "Division of Emergency Medicine, Ospedale degli Infermi, 13875 Ponderano, Italy"
}
],
"family": "Tonello",
"given": "Nadir",
"sequence": "additional"
},
{
"ORCID": "http://orcid.org/0000-0002-0836-0890",
"affiliation": [
{
"name": "Department of Translational Medicine, Università del Piemonte Orientale (UPO), 28100 Novara, Italy"
},
{
"name": "CAAD, Center for Autoimmune and Allergic Diseases, Università del Piemonte Orientale (UPO), 28100 Novara, Italy"
}
],
"authenticated-orcid": false,
"family": "Tonello",
"given": "Stelvio",
"sequence": "additional"
},
{
"affiliation": [
{
"name": "Division of Diabetology and Endocrinology, Ospedale degli Infermi, 13875 Ponderano, Italy"
}
],
"family": "Topazzo",
"given": "Gigliola",
"sequence": "additional"
},
{
"affiliation": [
{
"name": "Division of Emergency Medicine, Ospedale degli Infermi, 13875 Ponderano, Italy"
}
],
"family": "Tua",
"given": "Aldo",
"sequence": "additional"
},
{
"affiliation": [
{
"name": "Department of Public Health and Infectious Diseases, University of Rome, La Sapienza, 00185 Rome, Italy"
}
],
"family": "Valenti",
"given": "Piera",
"sequence": "additional"
},
{
"ORCID": "http://orcid.org/0000-0003-4625-4367",
"affiliation": [
{
"name": "Department of Translational Medicine, Università del Piemonte Orientale (UPO), 28100 Novara, Italy"
},
{
"name": "Department of Anesthesia and Intensive Care Medicine, AOU “Maggiore della Carità”, 28100 Novara, Italy"
}
],
"authenticated-orcid": false,
"family": "Vaschetto",
"given": "Rosanna",
"sequence": "additional"
},
{
"ORCID": "http://orcid.org/0000-0002-7097-0710",
"affiliation": [
{
"name": "Department of Translational Medicine, Università del Piemonte Orientale (UPO), 28100 Novara, Italy"
},
{
"name": "Department of Internal Medicine and COVID-19 Unit, Azienda Ospedaliero-Universitaria (AOU) “Maggiore della Carità”, 28100 Novara, Italy"
},
{
"name": "Division of Emergency Medicine and COVID-19 Sub-Intensive Unit, Azienda Ospedaliero-Universitaria (AOU) “Maggiore della Carità”, 28100 Novara, Italy"
}
],
"authenticated-orcid": false,
"family": "Vassia",
"given": "Veronica",
"sequence": "additional"
},
{
"ORCID": "http://orcid.org/0000-0003-2134-6986",
"affiliation": [
{
"name": "Department of Translational Medicine, Università del Piemonte Orientale (UPO), 28100 Novara, Italy"
},
{
"name": "Department of Internal Medicine and COVID-19 Unit, Azienda Ospedaliero-Universitaria (AOU) “Maggiore della Carità”, 28100 Novara, Italy"
},
{
"name": "Division of Emergency Medicine and COVID-19 Sub-Intensive Unit, Azienda Ospedaliero-Universitaria (AOU) “Maggiore della Carità”, 28100 Novara, Italy"
}
],
"authenticated-orcid": false,
"family": "Zecca",
"given": "Erika",
"sequence": "additional"
},
{
"affiliation": [
{
"name": "Division of Palliative Care, Ospedale degli Infermi, 13875 Ponderano, Italy"
}
],
"family": "Zublena",
"given": "Nicoletta",
"sequence": "additional"
},
{
"ORCID": "http://orcid.org/0000-0003-1340-3493",
"affiliation": [
{
"name": "Department of Maternal-Infant Medicine, Ospedale degli Infermi, 13875 Ponderano, Italy"
},
{
"name": "Internal Medicine, Department of Medical Sciences, Azienda Ospedaliero-Universitaria (AOU) Città della Salute e della Scienza, University of Turin School of Medicine, 10126 Turin, Italy"
}
],
"authenticated-orcid": false,
"family": "Manzoni",
"given": "Paolo",
"sequence": "additional"
},
{
"ORCID": "http://orcid.org/0000-0001-8322-9158",
"affiliation": [
{
"name": "Department of Translational Medicine, Università del Piemonte Orientale (UPO), 28100 Novara, Italy"
},
{
"name": "Department of Internal Medicine and COVID-19 Unit, Azienda Ospedaliero-Universitaria (AOU) “Maggiore della Carità”, 28100 Novara, Italy"
},
{
"name": "Division of Emergency Medicine and COVID-19 Sub-Intensive Unit, Azienda Ospedaliero-Universitaria (AOU) “Maggiore della Carità”, 28100 Novara, Italy"
},
{
"name": "CAAD, Center for Autoimmune and Allergic Diseases, Università del Piemonte Orientale (UPO), 28100 Novara, Italy"
}
],
"authenticated-orcid": false,
"family": "Sainaghi",
"given": "Pier Paolo",
"sequence": "additional"
}
],
"container-title": "Nutrients",
"container-title-short": "Nutrients",
"content-domain": {
"crossmark-restriction": false,
"domain": []
},
"created": {
"date-parts": [
[
2023,
3,
6
]
],
"date-time": "2023-03-06T06:35:30Z",
"timestamp": 1678084530000
},
"deposited": {
"date-parts": [
[
2023,
3,
6
]
],
"date-time": "2023-03-06T07:05:53Z",
"timestamp": 1678086353000
},
"indexed": {
"date-parts": [
[
2024,
3,
27
]
],
"date-time": "2024-03-27T18:28:55Z",
"timestamp": 1711564135547
},
"is-referenced-by-count": 7,
"issue": "5",
"issued": {
"date-parts": [
[
2023,
3,
4
]
]
},
"journal-issue": {
"issue": "5",
"published-online": {
"date-parts": [
[
2023,
3
]
]
}
},
"language": "en",
"license": [
{
"URL": "https://creativecommons.org/licenses/by/4.0/",
"content-version": "vor",
"delay-in-days": 0,
"start": {
"date-parts": [
[
2023,
3,
4
]
],
"date-time": "2023-03-04T00:00:00Z",
"timestamp": 1677888000000
}
}
],
"link": [
{
"URL": "https://www.mdpi.com/2072-6643/15/5/1285/pdf",
"content-type": "unspecified",
"content-version": "vor",
"intended-application": "similarity-checking"
}
],
"member": "1968",
"original-title": [],
"page": "1285",
"prefix": "10.3390",
"published": {
"date-parts": [
[
2023,
3,
4
]
]
},
"published-online": {
"date-parts": [
[
2023,
3,
4
]
]
},
"publisher": "MDPI AG",
"reference": [
{
"DOI": "10.1038/s41579-022-00713-0",
"article-title": "SARS-CoV-2 pathogenesis",
"author": "Lamers",
"doi-asserted-by": "crossref",
"first-page": "270",
"journal-title": "Nat. Rev. Microbiol.",
"key": "ref_1",
"volume": "20",
"year": "2022"
},
{
"DOI": "10.3389/fimmu.2022.835104",
"article-title": "Mechanistic Insights into the Immune Pathophysiology of COVID-19; An In-Depth Review",
"author": "Shafqat",
"doi-asserted-by": "crossref",
"first-page": "835104",
"journal-title": "Front. Immunol.",
"key": "ref_2",
"volume": "13",
"year": "2022"
},
{
"DOI": "10.1038/s41579-020-00459-7",
"article-title": "Characteristics of SARS-CoV-2 and COVID-19",
"author": "Hu",
"doi-asserted-by": "crossref",
"first-page": "141",
"journal-title": "Nat. Rev. Microbiol.",
"key": "ref_3",
"volume": "19",
"year": "2021"
},
{
"DOI": "10.1016/S2213-2600(21)00218-6",
"article-title": "The COVID-19 puzzle: Deciphering pathophysiology and phenotypes of a new disease entity",
"author": "Osuchowski",
"doi-asserted-by": "crossref",
"first-page": "622",
"journal-title": "Lancet Respir. Med.",
"key": "ref_4",
"volume": "9",
"year": "2021"
},
{
"DOI": "10.1038/s41598-021-00190-0",
"article-title": "Cytokine signature and COVID-19 prediction models in the two waves of pandemics",
"author": "Cabaro",
"doi-asserted-by": "crossref",
"first-page": "20793",
"journal-title": "Sci. Rep.",
"key": "ref_5",
"volume": "11",
"year": "2021"
},
{
"DOI": "10.3389/fmed.2021.733274",
"article-title": "Prognostic Role and Diagnostic Power of Seven Indicators in COVID-19 Patients",
"author": "Ding",
"doi-asserted-by": "crossref",
"first-page": "733274",
"journal-title": "Front. Med.",
"key": "ref_6",
"volume": "8",
"year": "2021"
},
{
"DOI": "10.1080/07853890.2022.2034936",
"article-title": "Efficacy and safety of three new oral antiviral treatment (molnupiravir, fluvoxamine and Paxlovid) for COVID-19: A meta-analysis",
"author": "Wen",
"doi-asserted-by": "crossref",
"first-page": "516",
"journal-title": "Ann. Med.",
"key": "ref_7",
"volume": "54",
"year": "2022"
},
{
"DOI": "10.1136/bmj.n2282",
"article-title": "Covid-19: Unvaccinated face 11 times risk of death from delta variant, CDC data show",
"author": "Dyer",
"doi-asserted-by": "crossref",
"first-page": "n2282",
"journal-title": "BMJ",
"key": "ref_8",
"volume": "374",
"year": "2021"
},
{
"DOI": "10.1007/s10238-020-00671-y",
"article-title": "Emerging treatment strategies for COVID-19 infection",
"author": "Gavriatopoulou",
"doi-asserted-by": "crossref",
"first-page": "167",
"journal-title": "Clin. Exp. Med.",
"key": "ref_9",
"volume": "21",
"year": "2021"
},
{
"DOI": "10.1016/j.clim.2020.108634",
"article-title": "COVID-19: A review of therapeutic strategies and vaccine candidates",
"author": "Izda",
"doi-asserted-by": "crossref",
"first-page": "108634",
"journal-title": "Clin. Immunol.",
"key": "ref_10",
"volume": "222",
"year": "2021"
},
{
"key": "ref_11",
"unstructured": "(2022, May 25). COVID-19 Treatment Guidelines Panel. Coronavirus Disease 2019 (COVID-19) Treatment Guidelines. National Institutes of Health, Available online: https://www.covid19treatmentguidelines.nih.gov."
},
{
"DOI": "10.1001/jamanetworkopen.2021.44942",
"article-title": "Efficacy of niclosamide vs placebo in SARS-CoV-2 respiratory viral clearance, viral shedding, and duration of symptoms among patients with mild to moderate COVID-19. A phase 2 randomized clinical trial",
"author": "Cairns",
"doi-asserted-by": "crossref",
"first-page": "e2144942",
"journal-title": "JAMA Netw. Open",
"key": "ref_12",
"volume": "5",
"year": "2022"
},
{
"DOI": "10.1073/pnas.2105815118",
"article-title": "Morphological cell profiling of SARS-CoV-2 infection identifies drug repurposing candidates for COVID-19",
"author": "Mirabelli",
"doi-asserted-by": "crossref",
"first-page": "e2105815118",
"journal-title": "Proc. Natl. Acad. Sci. USA",
"key": "ref_13",
"volume": "118",
"year": "2021"
},
{
"DOI": "10.3390/ijms22063134",
"doi-asserted-by": "crossref",
"key": "ref_14",
"unstructured": "Ricordi, C., Pacifici, F., Lanzoni, G., Palamara, A., Garaci, E., and Della-Morte, D. (2021). Dietary and Protective Factors to Halt or Mitigate Progression of Autoimmunity, COVID-19 and Its Associated Metabolic Diseases. Int. J. Mol. Sci., 22."
},
{
"DOI": "10.1016/j.biopha.2021.111228",
"article-title": "The role of iron in the pathogenesis of COVID-19 and possible treatment with lactoferrin and other iron chelators",
"author": "Habib",
"doi-asserted-by": "crossref",
"first-page": "111228",
"journal-title": "Biomed. Pharmacother.",
"key": "ref_15",
"volume": "136",
"year": "2021"
},
{
"DOI": "10.3390/jcm10235482",
"doi-asserted-by": "crossref",
"key": "ref_16",
"unstructured": "Presti, S., Manti, S., Parisi, G.F., Papale, M., Barbagallo, I.A., Li Volti, G., and Leonardi, S. (2021). Lactoferrin: Cytokine modulation and application in clinical partice. J. Clin. Med., 10."
},
{
"DOI": "10.1016/j.ijantimicag.2020.106118",
"article-title": "Lactoferrin as potential preventative and adjunct treatment for COVID-19",
"author": "Chang",
"doi-asserted-by": "crossref",
"first-page": "106118",
"journal-title": "Int. J. Antimicrob. Agents",
"key": "ref_17",
"volume": "56",
"year": "2020"
},
{
"DOI": "10.1371/journal.pone.0023710",
"doi-asserted-by": "crossref",
"key": "ref_18",
"unstructured": "Lang, J., Yang, N., Deng, J., Liu, K., Yang, P., Zhang, G., and Jiang, C. (2011). Inhibition of SARS Pseudovirus Cell Entry by Lactoferrin Binding to Heparan Sulfate Proteoglycans. PLoS ONE, 6."
},
{
"DOI": "10.1007/s10534-022-00427-z",
"doi-asserted-by": "crossref",
"key": "ref_19",
"unstructured": "Rosa, L., Cutone, A., Conte, M.P., Campione, E., Bianchi, L., and Valenti, P. (2022). An overview on in vitro and in vivo antiviral activity of lactoferrin: Its efficacy against SARS-CoV-2 infection. BioMetals, 1–20."
},
{
"DOI": "10.3168/jds.2021-21247",
"article-title": "Evaluating the in vitro efficacy of bovine lactoferrin products against SARS-CoV-2 variants of concern",
"author": "Wotring",
"doi-asserted-by": "crossref",
"first-page": "2791",
"journal-title": "J. Diary Sci.",
"key": "ref_20",
"volume": "105",
"year": "2022"
},
{
"DOI": "10.3389/fphar.2021.666600",
"article-title": "Lactoferrin against SARS-COV-2: In Vitro and in silico evidences",
"author": "Campione",
"doi-asserted-by": "crossref",
"first-page": "666600",
"journal-title": "Front. Pharmacol.",
"key": "ref_21",
"volume": "12",
"year": "2021"
},
{
"DOI": "10.1080/22221751.2021.1888660",
"article-title": "The in vitro antiviral activity of lactoferrin against common human coronaviruses and SARS-CoV-2 is mediated by targeting the heparan sulfate co-receptor",
"author": "Hu",
"doi-asserted-by": "crossref",
"first-page": "317",
"journal-title": "Emerg. Microbes Infect.",
"key": "ref_22",
"volume": "10",
"year": "2021"
},
{
"DOI": "10.3390/nu13020328",
"doi-asserted-by": "crossref",
"key": "ref_23",
"unstructured": "Salaris, C., Scarpa, M., Elli, M., Bertolini, A., Guglielmetti, S., Pregliasco, F., Blandizzi, C., Brun, P., and Castagliuolo, I. (2021). Protective effects of lactoferrin against SARS-CoV-2 infection in vitro. Nutrients, 13."
},
{
"DOI": "10.3389/fmolb.2021.607443",
"article-title": "Molecular mechanisms behind anti SARS-CoV-2 action of lactoferrin",
"author": "Miotto",
"doi-asserted-by": "crossref",
"first-page": "607443",
"journal-title": "Front. Mol. Biosci.",
"key": "ref_24",
"volume": "8",
"year": "2021"
},
{
"DOI": "10.3390/jcm10184276",
"doi-asserted-by": "crossref",
"key": "ref_25",
"unstructured": "Rosa, L., Tripepi, G., Naldi, E., Aimati, M., Santangeli, S., Venditto, F., Caldarelli, M., and Valenti, P. (2021). Ambulatory COVID-19 Patients Treated with Lactoferrin as a Supplementary Antiviral Agent: A Preliminary Study. J. Clin. Med., 10."
},
{
"article-title": "Effects of Probiotics and Lactoferrin on Necrotizing Enterocolitis in Preterm Infants",
"author": "Abdulaziz",
"first-page": "e18256",
"journal-title": "Cureus",
"key": "ref_26",
"volume": "13",
"year": "2021"
},
{
"DOI": "10.1139/bcb-2020-0046",
"article-title": "Effect of bovine lactoferrin on prevention of late-onset sepsis in infants < 1500 g: A pooled analysis of individual patient data from two randomized controlled trials",
"author": "Ochoa",
"doi-asserted-by": "crossref",
"first-page": "14",
"journal-title": "Biochem. Cell Biol.",
"key": "ref_27",
"volume": "99",
"year": "2021"
},
{
"DOI": "10.1016/j.jpeds.2019.12.038",
"article-title": "Randomized controlled trial of bovine lactoferrin for prevention of sepsis and neuro-development impairment in infants weighing less than 2000 grams",
"author": "Ochoa",
"doi-asserted-by": "crossref",
"first-page": "118",
"journal-title": "J. Pediatr.",
"key": "ref_28",
"volume": "219",
"year": "2020"
},
{
"DOI": "10.1016/S2352-4642(20)30093-6",
"article-title": "The effect of lactoferrin supplementation on death or major morbidity in very low birthweight infants (LIFT): A multicentre, double-blind, randomised controlled trial",
"author": "Martin",
"doi-asserted-by": "crossref",
"first-page": "444",
"journal-title": "Lancet Child Adolesc. Health",
"key": "ref_29",
"volume": "4",
"year": "2020"
},
{
"key": "ref_30",
"unstructured": "ELFIN Trial Investigators Group (2019). Enteral lactoferrin supplementation for very preterm infants: A randomized place-bo-controlled trial. Lancet, 393, 423–433."
},
{
"DOI": "10.3310/hta22740",
"article-title": "Enteral lactoferrin to prevent infection for very preterm infants: The ELFIN RCT",
"author": "Griffiths",
"doi-asserted-by": "crossref",
"first-page": "1",
"journal-title": "Health Technol. Assess.",
"key": "ref_31",
"volume": "22",
"year": "2018"
},
{
"DOI": "10.1097/MD.0000000000011976",
"article-title": "Prophylactic lactoferrin for preventing late-onset sepsis and necrotizing enterocolitis in preterm infants. A PRISMA-complaint systematic review and meta-analysis",
"author": "He",
"doi-asserted-by": "crossref",
"first-page": "e11976",
"journal-title": "Medicine",
"key": "ref_32",
"volume": "97",
"year": "2018"
},
{
"DOI": "10.1038/jp.2016.24",
"article-title": "The Lacuna Trial: A double-blind randomized controlled pilot trial of lactoferrin supplementation in the very preterm infant",
"author": "Barrington",
"doi-asserted-by": "crossref",
"first-page": "666",
"journal-title": "J. Perinatol.",
"key": "ref_33",
"volume": "36",
"year": "2016"
},
{
"DOI": "10.1093/tropej/fmv044",
"article-title": "Efficacy of bovine lactoferrin supplementation in preventing late-onset sepsis in low birth weight neo-nates: A randomized placebo-controlled clinical trial",
"author": "Kaur",
"doi-asserted-by": "crossref",
"first-page": "370",
"journal-title": "J. Trop. Pediatr.",
"key": "ref_34",
"volume": "61",
"year": "2015"
},
{
"DOI": "10.1097/INF.0000000000000593",
"article-title": "Randomized Controlled Trial of Lactoferrin for Prevention of Sepsis in Peruvian Neonates Less than 2500 g",
"author": "Ochoa",
"doi-asserted-by": "crossref",
"first-page": "571",
"journal-title": "Pediatr. Infect. Dis. J.",
"key": "ref_35",
"volume": "34",
"year": "2015"
},
{
"DOI": "10.1016/S0378-3782(14)70020-9",
"article-title": "Bovine lactoferrin supplementation for prevention of necrotizing enterocolitis in very-low-birth-weight neonates: A randomized clinical trial",
"author": "Manzoni",
"doi-asserted-by": "crossref",
"first-page": "S60",
"journal-title": "Early Hum. Dev.",
"key": "ref_36",
"volume": "90",
"year": "2014"
},
{
"DOI": "10.1001/jama.2009.1403",
"article-title": "Bovine lactoferrin supplementation for prevention of late-onset sepsis in very low-birth-weight neonates: A randomized trial",
"author": "Manzoni",
"doi-asserted-by": "crossref",
"first-page": "1421",
"journal-title": "JAMA",
"key": "ref_37",
"volume": "302",
"year": "2009"
},
{
"DOI": "10.3390/ijerph182010985",
"doi-asserted-by": "crossref",
"key": "ref_38",
"unstructured": "Campione, E., Lanna, C., Cosio, T., Rosa, L., Conte, M.P., Iacovelli, F., Romeo, A., Falconi, M., Del Vecchio, C., and Franchin, E. (2021). Lactoferrin as Antiviral Treatment in COVID-19 Management: Preliminary Evidence. Int. J. Environ. Res. Public Health, 18."
},
{
"article-title": "Liposomal Lactoferrin as Potential Preventative and Cure for COVID-19",
"author": "Serrano",
"first-page": "08",
"journal-title": "Int. J. Res. Health Sci.",
"key": "ref_39",
"volume": "8",
"year": "2020"
},
{
"DOI": "10.4103/0974-1208.82352",
"article-title": "An overview of randomization techniques: An unbiased assessment of outcome in clinical research",
"author": "Suresh",
"doi-asserted-by": "crossref",
"first-page": "8",
"journal-title": "J. Hum. Reprod. Sci.",
"key": "ref_40",
"volume": "4",
"year": "2011"
},
{
"DOI": "10.1001/jama.2018.6360",
"article-title": "Randomization in clinical trials. Permuted blocks and stratification",
"author": "Broglio",
"doi-asserted-by": "crossref",
"first-page": "223",
"journal-title": "JAMA",
"key": "ref_41",
"volume": "319",
"year": "2018"
},
{
"DOI": "10.1016/j.jbi.2008.08.010",
"article-title": "Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics support",
"author": "Harris",
"doi-asserted-by": "crossref",
"first-page": "377",
"journal-title": "J. Biomed. Inform.",
"key": "ref_42",
"volume": "42",
"year": "2009"
},
{
"key": "ref_43",
"unstructured": "R Core Team (2015). A Language and Environment for Statistical Computing, R Core Team. R Foundation for Statistical Computing."
},
{
"key": "ref_44",
"unstructured": "Champely, S., Ekstrom, C., Dalgaard, P., Gill, J., Weibelzahl, S., Anandkumar, A., Ford, C., Volcic, R., and De Rosario, H. (2020, December 15). Package “Pwr”, R Package Version. Available online: https://CRAN.R-project.org/package=pwr."
},
{
"DOI": "10.3390/medicina57080842",
"doi-asserted-by": "crossref",
"key": "ref_45",
"unstructured": "Algahtani, F.D., ELabbasy, M.T., Sanak, M.A., Adeboye, A.A., Yusuf, R.A., and Ghoniem, M.E. (2021). The prospect of lactoferrin use ad adjunctive agent in management of SARS-CoV-2 patients: A randomized pilot study. Medicina, 57."
},
{
"DOI": "10.1016/j.intimp.2007.05.019",
"article-title": "Uptake of ingested bovine lactoferrin and its accumulation in adult mouse tissues",
"author": "Fischer",
"doi-asserted-by": "crossref",
"first-page": "1387",
"journal-title": "Int. Immunopharmacol.",
"key": "ref_46",
"volume": "7",
"year": "2007"
},
{
"DOI": "10.1292/jvms.65.567",
"article-title": "Persorption of bovine lactoferrin from the intestinal lumen into the systemic circulation via the portal vein and the mesenteric lymphatics in growing pigs",
"author": "Kitagawa",
"doi-asserted-by": "crossref",
"first-page": "567",
"journal-title": "J. Vet.-Med. Sci.",
"key": "ref_47",
"volume": "65",
"year": "2003"
},
{
"DOI": "10.1023/B:BIOM.0000027710.13543.3f",
"article-title": "Cellular internalization of lactoferrin in intestinal epithelial cells",
"author": "Ashida",
"doi-asserted-by": "crossref",
"first-page": "311",
"journal-title": "Biometals",
"key": "ref_48",
"volume": "17",
"year": "2004"
},
{
"article-title": "Isolation and function of a receptor for human lactoferrin in human fetal intestinal brush-border membranes",
"author": "Kawakami",
"first-page": "G841",
"journal-title": "Am. J. Physiol.",
"key": "ref_49",
"volume": "261",
"year": "1991"
},
{
"DOI": "10.1002/jcp.22650",
"article-title": "Apo- and holo-lactoferrin are both internalized by lactoferrin receptor via clathrin-mediated endocytosis but differentially affect ERK-signaling and cell proliferation in caco-2 cells",
"author": "Jiang",
"doi-asserted-by": "crossref",
"first-page": "3022",
"journal-title": "J. Cell. Physiol.",
"key": "ref_50",
"volume": "226",
"year": "2011"
},
{
"DOI": "10.1042/BJ20070393",
"article-title": "Lactoferrin receptor mediates apo- but not hol-lactoferrin internalization via clath-rin-mediated endocytosis in trophoblasts",
"author": "Lopez",
"doi-asserted-by": "crossref",
"first-page": "271",
"journal-title": "Biochem. J.",
"key": "ref_51",
"volume": "411",
"year": "2008"
},
{
"DOI": "10.1007/s00018-005-5371-1",
"article-title": "Mammalian lactoferrin receptors: Structure and function",
"author": "Suzuki",
"doi-asserted-by": "crossref",
"first-page": "2560",
"journal-title": "Cell. Mol. Life Sci.",
"key": "ref_52",
"volume": "62",
"year": "2005"
},
{
"DOI": "10.1056/NEJMoa2116846",
"article-title": "Early Remdesivir to Prevent Progression to Severe Covid-19 in Outpatients",
"author": "Gottlieb",
"doi-asserted-by": "crossref",
"first-page": "305",
"journal-title": "N. Engl. J. Med.",
"key": "ref_53",
"volume": "386",
"year": "2022"
},
{
"DOI": "10.1002/14651858.CD014962",
"doi-asserted-by": "crossref",
"key": "ref_54",
"unstructured": "Ansems, K., Grundeis, F., Dahms, K., Mikolajewska, A., Thieme, V., Piechotta, V., Metzendorf, M.I., Stegemann, M., Benstoem, C., and Fichtner, F. (2022, August 08). Remdesivir for the Treatment of COIVD-19. Cochrane Database of Systematic Reviews. Art. N:CD014962. Available online: https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD014962/full."
},
{
"article-title": "Randomized Trial of Molnupiravir or Placebo in Patients Hospitalized with COVID-19",
"author": "Arribas",
"first-page": "EVIDoa2100044",
"journal-title": "NEJM Évid.",
"key": "ref_55",
"volume": "1",
"year": "2022"
},
{
"DOI": "10.1007/s10534-010-9297-1",
"article-title": "A critical review of the roles of host lactoferrin in immunity",
"author": "Legrand",
"doi-asserted-by": "crossref",
"first-page": "365",
"journal-title": "Biometals",
"key": "ref_56",
"volume": "23",
"year": "2010"
},
{
"DOI": "10.4187/respcare.06314",
"article-title": "Clinical Pharmacology of Corticosteroids",
"author": "Williams",
"doi-asserted-by": "crossref",
"first-page": "655",
"journal-title": "Respir. Care",
"key": "ref_57",
"volume": "63",
"year": "2018"
},
{
"DOI": "10.1038/sj.bjp.0706736",
"article-title": "How corticosteroids control inflammation: Quintiles Prize Lecture 2005",
"author": "Barnes",
"doi-asserted-by": "crossref",
"first-page": "245",
"journal-title": "Br. J. Pharmacol.",
"key": "ref_58",
"volume": "148",
"year": "2006"
},
{
"DOI": "10.1016/j.crvi.2014.08.003",
"article-title": "Potential lactoferrin activity against pathogenic viruses",
"author": "Redwan",
"doi-asserted-by": "crossref",
"first-page": "581",
"journal-title": "Comptes Rendus Biol.",
"key": "ref_59",
"volume": "337",
"year": "2014"
},
{
"article-title": "Potential role of lactoferrin and heparin in COIVD-19: A review",
"author": "Hoxa",
"first-page": "14",
"journal-title": "Eur. Sci. J. ESJ",
"key": "ref_60",
"volume": "17",
"year": "2021"
},
{
"DOI": "10.1002/jmv.20171",
"article-title": "Anti-HSV activity of lactoferrin and lactoferricin is dependent on the presence of heparan sulphate at the cell surface",
"author": "Andersen",
"doi-asserted-by": "crossref",
"first-page": "262",
"journal-title": "J. Med. Virol.",
"key": "ref_61",
"volume": "74",
"year": "2004"
},
{
"DOI": "10.1016/j.bbi.2020.04.077",
"article-title": "COVID-19 presenting as stroke",
"author": "Avula",
"doi-asserted-by": "crossref",
"first-page": "115",
"journal-title": "Brain Behav. Immun.",
"key": "ref_62",
"volume": "87",
"year": "2020"
},
{
"DOI": "10.1016/S0968-0004(03)00031-8",
"article-title": "Heparan sulfate proteoglycan as a plasma membrane carrier",
"author": "Belting",
"doi-asserted-by": "crossref",
"first-page": "145",
"journal-title": "Trends Biochem. Sci.",
"key": "ref_63",
"volume": "28",
"year": "2003"
},
{
"DOI": "10.3390/molecules16086992",
"article-title": "Antiviral properties of lactoferrin—A natural immunity molecule",
"author": "Berlutti",
"doi-asserted-by": "crossref",
"first-page": "6992",
"journal-title": "Molecules",
"key": "ref_64",
"volume": "16",
"year": "2011"
},
{
"DOI": "10.3390/ijms21144903",
"doi-asserted-by": "crossref",
"key": "ref_65",
"unstructured": "Campione, E., Cosio, T., Rosa, L., Lanna, C., Di Girolamo, S., Gaziano, R., Valenti, P., and Bianchi, L. (2020). Lactoferrin as protective natural barrier of respiratory and intestinal mucosa against coronavirus infection and inflammation. Int. J. Mol. Sci., 21."
},
{
"key": "ref_66",
"unstructured": "Campione, E., Lanna, C., Cosio, T., Rosa, L., Conte, M.P., Iacovelli, F., Romeo, A., Falconi, M., Del Vecchio, C., and Franchin, E. (2020). Pleiotropic effect of lactoferrin in the prevention and treatment of COIVD-19 infection: In Vivo, in silico and in vitro preliminary evidences. BioRxiv, Available online: https://www.biorxiv.org/content/10.1101/2020.08.11.244996v2.full.pdf."
},
{
"DOI": "10.1016/j.virol.2014.01.022",
"article-title": "Inhibition of Mayaro virus infection by bovine lactoferrin",
"author": "Carvalho",
"doi-asserted-by": "crossref",
"first-page": "297",
"journal-title": "Virology",
"key": "ref_67",
"volume": "452-453",
"year": "2014"
},
{
"DOI": "10.1002/jmv.25681",
"article-title": "Emerging coronaviruses: Genome structure, replication, and pathogenesis",
"author": "Chen",
"doi-asserted-by": "crossref",
"first-page": "418",
"journal-title": "J. Med. Virol.",
"key": "ref_68",
"volume": "92",
"year": "2020"
},
{
"DOI": "10.1128/CMR.00028-20",
"article-title": "Coronavirus Disease 2019-COVID-19",
"author": "Dhama",
"doi-asserted-by": "crossref",
"first-page": "e00028-20",
"journal-title": "Clin. Microbiol. Rev.",
"key": "ref_69",
"volume": "33",
"year": "2020"
},
{
"DOI": "10.1016/S1473-3099(20)30120-1",
"article-title": "An interactive web-based dashboard to track COVID-19 in real time",
"author": "Dong",
"doi-asserted-by": "crossref",
"first-page": "533",
"journal-title": "Lancet Infect. Dis.",
"key": "ref_70",
"volume": "20",
"year": "2020"
},
{
"DOI": "10.1111/jce.14479",
"article-title": "Cardiac and arrhythmic complications in patients with COVID-19",
"author": "Kochi",
"doi-asserted-by": "crossref",
"first-page": "1003",
"journal-title": "J. Cardiovasc. Electrophysiol.",
"key": "ref_71",
"volume": "31",
"year": "2020"
},
{
"DOI": "10.1139/o06-045",
"article-title": "Interactions of lactoferrin with cells involved in immune function",
"author": "Legrand",
"doi-asserted-by": "crossref",
"first-page": "282",
"journal-title": "Biochem. Cell Biol.",
"key": "ref_72",
"volume": "84",
"year": "2006"
},
{
"DOI": "10.1136/gutjnl-2020-321013",
"article-title": "Gastrointestinal symptoms of 95 cases with SARS-CoV-2 infection",
"author": "Lin",
"doi-asserted-by": "crossref",
"first-page": "997",
"journal-title": "Gut",
"key": "ref_73",
"volume": "69",
"year": "2020"
},
{
"DOI": "10.3390/ijms18091985",
"doi-asserted-by": "crossref",
"key": "ref_74",
"unstructured": "Rosa, L., Cutone, A., Lepanto, M.S., Paesano, R., and Valenti, P. (2017). Lactoferrin: A natural glycoprotein involved in iron and inflammatory homeostasis. Int. J. Mol. Sci., 18."
},
{
"DOI": "10.1111/j.1742-4658.2009.07400.x",
"article-title": "Viral entry mechanisms: Human papillomavirus and a long journey from extracellular matrix to the nucleus",
"author": "Sapp",
"doi-asserted-by": "crossref",
"first-page": "7206",
"journal-title": "FEBS J.",
"key": "ref_75",
"volume": "276",
"year": "2009"
},
{
"DOI": "10.1111/j.1462-5822.2004.00389.x",
"article-title": "Herpes simplex virus: Receptors and ligands for cell entry",
"author": "Spear",
"doi-asserted-by": "crossref",
"first-page": "401",
"journal-title": "Cell Microbiol.",
"key": "ref_76",
"volume": "6",
"year": "2004"
},
{
"DOI": "10.1007/s00018-005-5372-0",
"article-title": "Lactoferrin: An important host defence against microbial and viral attack",
"author": "Valenti",
"doi-asserted-by": "crossref",
"first-page": "2576",
"journal-title": "Cell Mol. Life Sci.",
"key": "ref_77",
"volume": "62",
"year": "2005"
},
{
"DOI": "10.1016/j.jiac.2014.08.003",
"article-title": "Lactoferrin for prevention of common viral infections",
"author": "Wakabayashi",
"doi-asserted-by": "crossref",
"first-page": "666",
"journal-title": "J. Infect Chemother.",
"key": "ref_78",
"volume": "20",
"year": "2014"
},
{
"DOI": "10.1016/j.cell.2020.03.045",
"article-title": "Structural and functional basis of SARS-CoV-2 entry by using human ACE2",
"author": "Wang",
"doi-asserted-by": "crossref",
"first-page": "894",
"journal-title": "Cell",
"key": "ref_79",
"volume": "181",
"year": "2020"
},
{
"DOI": "10.3892/etm.2020.9402",
"article-title": "Lactoferrin for the treatment of COVID-19",
"author": "Wang",
"doi-asserted-by": "crossref",
"first-page": "272",
"journal-title": "Exp. Ther. Med.",
"key": "ref_80",
"volume": "20",
"year": "2020"
},
{
"DOI": "10.1053/j.gastro.2020.02.055",
"article-title": "Evidence for gastrointestinal infection of SARS-CoV-2",
"author": "Xiao",
"doi-asserted-by": "crossref",
"first-page": "1831",
"journal-title": "Gastroenterology",
"key": "ref_81",
"volume": "158",
"year": "2020"
},
{
"DOI": "10.3390/nu10091235",
"doi-asserted-by": "crossref",
"key": "ref_82",
"unstructured": "Yang, Z., Jiang, R., Chen, Q., Wang, J., Duan, Y., Pang, X., Jiang, S., Bi, Y., Zhang, H., and Lönnerdal, B. (2018). Concentration of lactoferrin in human milk and its variation during lactation in different Chinese populations. Nutrients, 10."
},
{
"key": "ref_83",
"unstructured": "Rosemberger, W.F., and Lachin, J.M. (2002). Wiley Online Library."
},
{
"key": "ref_84",
"unstructured": "Cohen, J. (1977). Academic Press."
}
],
"reference-count": 84,
"references-count": 84,
"relation": {},
"resource": {
"primary": {
"URL": "https://www.mdpi.com/2072-6643/15/5/1285"
}
},
"score": 1,
"short-title": [],
"source": "Crossref",
"subject": [
"Food Science",
"Nutrition and Dietetics"
],
"subtitle": [],
"title": "Effect of Lactoferrin on Clinical Outcomes of Hospitalized Patients with COVID-19: The LAC Randomized Clinical Trial",
"type": "journal-article",
"volume": "15"
}
